{
  "DOI": "10.1186/s40246-022-00441-9",
  "ISSN": [
    "1479-7364"
  ],
  "URL": "http://dx.doi.org/10.1186/s40246-022-00441-9",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eBackground\u003c/jats:title\u003e\n                \u003cjats:p\u003eThe tripartite motif (TRIM) proteins function as important regulators in innate immunity, tumorigenesis, cell differentiation and ontogenetic development. However, we still lack knowledge about the genetic and transcriptome alterations landscape of TRIM proteins across cancer types.\n\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eMethods\u003c/jats:title\u003e\n                \u003cjats:p\u003eWe comprehensively reviewed and characterized the perturbations of TRIM genes across \u0026gt; 10,000 samples across 33 cancer types. Genetic mutations and transcriptome of TRIM genes were analyzed by diverse computational methods. A TRIMs score index was calculated based on the expression of TRIM genes. The correlation between TRIMs scores and clinical associations, immune cell infiltrations and immunotherapy response were analyzed by correlation coefficients and gene set enrichment analysis.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eResults\u003c/jats:title\u003e\n                \u003cjats:p\u003eAlterations in TRIM genes and protein levels frequently emerge in a wide range of tumors and affect expression of TRIM genes. In particular, mutations located in domains are likely to be deleterious mutations. Perturbations of TRIM genes are correlated with expressions of immune checkpoints and immune cell infiltrations, which further regulated the cancer- and immune-related pathways. Moreover, we proposed a TRIMs score index, which can accurately predict the clinical outcome of cancer patients. TRIMs scores of patients are correlated with clinical survival and immune therapy response across cancer types. Identifying the TRIM genes with genetic and transcriptome alterations will directly contribute to cancer therapy in the context of predictive, preventive, and personalized medicine.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eConclusions\u003c/jats:title\u003e\n                \u003cjats:p\u003eOur study provided a comprehensive analysis and resource for guiding both mechanistic and therapeutic analyses of the roles of TRIM genes in cancer.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e",
  "alternative-id": [
    "441"
  ],
  "article-number": "65",
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "27 July 2022"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "28 November 2022"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "2 December 2022"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Ethics approval and consent to participate",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "Not applicable."
    },
    {
      "group": {
        "label": "Consent for publication",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "Not applicable."
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 4,
      "value": "No potential competing interests were disclosed."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Gao",
      "given": "Yueying",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Pan",
      "given": "Tao",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Xu",
      "given": "Gang",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Li",
      "given": "Si",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Guo",
      "given": "Jing",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Zhang",
      "given": "Ya",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Xu",
      "given": "Qi",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Pan",
      "given": "Jiwei",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Ma",
      "given": "Yanlin",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Xu",
      "given": "Juan",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Li",
      "given": "Yongsheng",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genomics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2022,
        12,
        2
      ]
    ],
    "date-time": "2022-12-02T15:11:56Z",
    "timestamp": 1669993916000
  },
  "deposited": {
    "date-parts": [
      [
        2022,
        12,
        2
      ]
    ],
    "date-time": "2022-12-02T18:09:41Z",
    "timestamp": 1670004581000
  },
  "funder": [
    {
      "award": [
        "Qhys2021-350"
      ],
      "name": "Innovation Research Fund for Graduate Students"
    },
    {
      "DOI": "10.13039/501100001809",
      "award": [
        "32060152",
        "32070673",
        "32170676",
        "31871338",
        "31970646",
        "61873075",
        "82072880"
      ],
      "doi-asserted-by": "publisher",
      "name": "National Natural Science Foundation of China"
    },
    {
      "award": [
        "820MS053",
        "822MS175",
        "LCYX201202"
      ],
      "name": "Hainan Provincial Natural Science Foundation of China"
    },
    {
      "award": [
        "ZDKJ202003"
      ],
      "name": "Major Science and Technology Program of Hainan Province"
    },
    {
      "award": [
        "HMUMIF-21024"
      ],
      "name": "HMU MarshalI Initiative Funding"
    },
    {
      "DOI": "10.13039/501100012166",
      "award": [
        "2018YFC2000100"
      ],
      "doi-asserted-by": "crossref",
      "name": "National Key R\u0026D Program of China"
    },
    {
      "award": [
        "JQ2019C004"
      ],
      "name": "Natural Science Foundation for Distinguished Young Scholars of Heilongjiang Province"
    },
    {
      "name": "Heilongjiang Touyan Innovation Team Program"
    },
    {
      "award": [
        "ZDYF2021SHFZ051"
      ],
      "name": "Hainan Province Science and Technology Special Fund"
    },
    {
      "award": [
        "JBGS202103"
      ],
      "name": "Marshal Initiative Funding of Hainan Medical University"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        3,
        28
      ]
    ],
    "date-time": "2024-03-28T07:55:57Z",
    "timestamp": 1711612557722
  },
  "is-referenced-by-count": 3,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1479-7364"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2022,
        12,
        2
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-online": {
      "date-parts": [
        [
          2022,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2022,
            12,
            2
          ]
        ],
        "date-time": "2022-12-02T00:00:00Z",
        "timestamp": 1669939200000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2022,
            12,
            2
          ]
        ],
        "date-time": "2022-12-02T00:00:00Z",
        "timestamp": 1669939200000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-022-00441-9.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1186/s40246-022-00441-9/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-022-00441-9.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1186",
  "published": {
    "date-parts": [
      [
        2022,
        12,
        2
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2022,
        12,
        2
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1016/j.tibs.2017.01.002",
      "author": "S Hatakeyama",
      "doi-asserted-by": "publisher",
      "first-page": "297",
      "journal-title": "Trends Biochem Sci",
      "key": "441_CR1",
      "unstructured": "Hatakeyama S. TRIM family proteins: roles in autophagy, immunity, and carcinogenesis. Trends Biochem Sci. 2017;42:297–311.",
      "volume": "42",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.omtn.2020.08.034",
      "author": "U Bhaduri",
      "doi-asserted-by": "publisher",
      "first-page": "434",
      "journal-title": "Mol Ther Nucleic Acids",
      "key": "441_CR2",
      "unstructured": "Bhaduri U, Merla G. Rise of TRIM8: a molecule of duality. Mol Ther Nucleic Acids. 2020;22:434–44.",
      "volume": "22",
      "year": "2020"
    },
    {
      "DOI": "10.1016/j.intimp.2021.107813",
      "author": "Z Jin",
      "doi-asserted-by": "publisher",
      "first-page": "107813",
      "journal-title": "Int Immunopharmacol",
      "key": "441_CR3",
      "unstructured": "Jin Z, Zhu Z. The role of TRIM proteins in PRR signaling pathways and immune-related diseases. Int Immunopharmacol. 2021;98:107813.",
      "volume": "98",
      "year": "2021"
    },
    {
      "DOI": "10.1002/emmm.201100160",
      "author": "T Kawai",
      "doi-asserted-by": "publisher",
      "first-page": "513",
      "journal-title": "EMBO Mol Med",
      "key": "441_CR4",
      "unstructured": "Kawai T, Akira S. Regulation of innate immune signalling pathways by the tripartite motif (TRIM) family proteins. EMBO Mol Med. 2011;3:513–27.",
      "volume": "3",
      "year": "2011"
    },
    {
      "DOI": "10.1007/s10555-017-9703-z",
      "author": "D Wang",
      "doi-asserted-by": "publisher",
      "first-page": "683",
      "journal-title": "Cancer Metastasis Rev",
      "key": "441_CR5",
      "unstructured": "Wang D, Ma L, Wang B, Liu J, Wei W. E3 ubiquitin ligases in cancer and implications for therapies. Cancer Metastasis Rev. 2017;36:683–702.",
      "volume": "36",
      "year": "2017"
    },
    {
      "DOI": "10.1053/j.gastro.2014.07.021",
      "author": "Z Zhou",
      "doi-asserted-by": "publisher",
      "first-page": "1043",
      "journal-title": "Gastroenterology",
      "key": "441_CR6",
      "unstructured": "Zhou Z, Ji Z, Wang Y, Li J, Cao H, Zhu HH, Gao WQ. TRIM59 is up-regulated in gastric tumors, promoting ubiquitination and degradation of p53. Gastroenterology. 2014;147:1043–54.",
      "volume": "147",
      "year": "2014"
    },
    {
      "DOI": "10.1038/cdd.2014.121",
      "author": "J Liu",
      "doi-asserted-by": "publisher",
      "first-page": "1792",
      "journal-title": "Cell Death Differ",
      "key": "441_CR7",
      "unstructured": "Liu J, Zhang C, Wang XL, Ly P, Belyi V, Xu-Monette ZY, Young KH, Hu W, Feng Z. E3 ubiquitin ligase TRIM32 negatively regulates tumor suppressor p53 to promote tumorigenesis. Cell Death Differ. 2014;21:1792–804.",
      "volume": "21",
      "year": "2014"
    },
    {
      "DOI": "10.1038/onc.2016.33",
      "author": "S Elabd",
      "doi-asserted-by": "publisher",
      "first-page": "5577",
      "journal-title": "Oncogene",
      "key": "441_CR8",
      "unstructured": "Elabd S, Meroni G, Blattner C. TRIMming p53’s anticancer activity. Oncogene. 2016;35:5577–84.",
      "volume": "35",
      "year": "2016"
    },
    {
      "DOI": "10.1007/s12253-019-00629-w",
      "author": "MJ Fernandez-Acenero",
      "doi-asserted-by": "publisher",
      "first-page": "861",
      "journal-title": "Pathol Oncol Res",
      "key": "441_CR9",
      "unstructured": "Fernandez-Acenero MJ, Cruz M, Sastre-Varela J, Casal JI, Nieto MAC, Del Puerto-Nevado L, Garcia-Foncillas J, Cebrian A. TRIM72 immunohistochemical expression can predict relapse in colorectal carcinoma. Pathol Oncol Res. 2020;26:861–5.",
      "volume": "26",
      "year": "2020"
    },
    {
      "DOI": "10.1002/cam4.1537",
      "author": "XM Lyu",
      "doi-asserted-by": "publisher",
      "first-page": "3848",
      "journal-title": "Cancer Med",
      "key": "441_CR10",
      "unstructured": "Lyu XM, Zhu XW, Zhao M, Zuo XB, Huang ZX, Liu X, Jiang T, Yang XX, Li X, Long XB, et al. A regulatory mutant on TRIM26 conferring the risk of nasopharyngeal carcinoma by inducing low immune response. Cancer Med. 2018;7:3848–61.",
      "volume": "7",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.cytogfr.2013.07.002",
      "author": "X Liu",
      "doi-asserted-by": "publisher",
      "first-page": "559",
      "journal-title": "Cytokine Growth Factor Rev",
      "key": "441_CR11",
      "unstructured": "Liu X, Wang Q, Chen W, Wang C. Dynamic regulation of innate immunity by ubiquitin and ubiquitin-like proteins. Cytokine Growth Factor Rev. 2013;24:559–70.",
      "volume": "24",
      "year": "2013"
    },
    {
      "DOI": "10.1016/j.semcdb.2020.09.013",
      "author": "HT Wang",
      "doi-asserted-by": "publisher",
      "first-page": "76",
      "journal-title": "Semin Cell Dev Biol",
      "key": "441_CR12",
      "unstructured": "Wang HT, Hur S. Substrate recognition by TRIM and TRIM-like proteins in innate immunity. Semin Cell Dev Biol. 2021;111:76–85.",
      "volume": "111",
      "year": "2021"
    },
    {
      "DOI": "10.3389/fimmu.2020.02157",
      "author": "W Yang",
      "doi-asserted-by": "publisher",
      "first-page": "02157",
      "journal-title": "Front Immunol",
      "key": "441_CR13",
      "unstructured": "Yang W, Gu Z, Zhang H, Hu H. To TRIM the immunity: from innate to adaptive immunity. Front Immunol. 2020;11:02157.",
      "volume": "11",
      "year": "2020"
    },
    {
      "DOI": "10.1016/j.cytogfr.2014.08.001",
      "author": "GA Versteeg",
      "doi-asserted-by": "publisher",
      "first-page": "563",
      "journal-title": "Cytokine Growth Factor Rev",
      "key": "441_CR14",
      "unstructured": "Versteeg GA, Benke S, Garcia-Sastre A, Rajsbaum R. InTRIMsic immunity: positive and negative regulation of immune signaling by tripartite motif proteins. Cytokine Growth Factor Rev. 2014;25:563–76.",
      "volume": "25",
      "year": "2014"
    },
    {
      "DOI": "10.3390/v12020131",
      "author": "G Patil",
      "doi-asserted-by": "publisher",
      "first-page": "131",
      "journal-title": "Viruses",
      "key": "441_CR15",
      "unstructured": "Patil G, Xu L, Wu Y, Song K, Hao W, Hua F, Wang L, Li S. TRIM41-mediated ubiquitination of nucleoprotein limits vesicular stomatitis virus infection. Viruses. 2020;12:131.",
      "volume": "12",
      "year": "2020"
    },
    {
      "DOI": "10.1371/journal.pone.0142596",
      "author": "W Zhan",
      "doi-asserted-by": "publisher",
      "first-page": "e0142596",
      "journal-title": "PLoS ONE",
      "key": "441_CR16",
      "unstructured": "Zhan W, Han T, Zhang C, Xie C, Gan M, Deng K, Fu M, Wang JB. TRIM59 promotes the proliferation and migration of non-small cell lung cancer cells by upregulating cell cycle related proteins. PLoS ONE. 2015;10:e0142596.",
      "volume": "10",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.canlet.2019.12.030",
      "author": "H Ying",
      "doi-asserted-by": "publisher",
      "first-page": "13",
      "journal-title": "Cancer Lett",
      "key": "441_CR17",
      "unstructured": "Ying H, Ji L, Xu Z, Fan X, Tong Y, Liu H, Zhao J, Cai X. TRIM59 promotes tumor growth in hepatocellular carcinoma and regulates the cell cycle by degradation of protein phosphatase 1B. Cancer Lett. 2020;473:13–24.",
      "volume": "473",
      "year": "2020"
    },
    {
      "author": "WY Lin",
      "first-page": "4864",
      "journal-title": "Eur Rev Med Pharmacol Sci",
      "key": "441_CR18",
      "unstructured": "Lin WY, Wang H, Song X, Zhang SX, Zhou PS, Sun JM, Li JS. Knockdown of tripartite motif 59 (TRIM59) inhibits tumor growth in prostate cancer. Eur Rev Med Pharmacol Sci. 2016;20:4864–73.",
      "volume": "20",
      "year": "2016"
    },
    {
      "author": "R Liu",
      "first-page": "6",
      "journal-title": "Oncol Lett",
      "key": "441_CR19",
      "unstructured": "Liu R, Li H, Xu Y, Li X, Guo X, Shi J, Cui Y, Wang Z, Liu J. Blockade of TRIM59 enhances esophageal cancer cell chemosensitivity to cisplatin by upregulating p53. Oncol Lett. 2021;21:6.",
      "volume": "21",
      "year": "2021"
    },
    {
      "DOI": "10.1093/nar/gkaa1100",
      "author": "C UniProt",
      "doi-asserted-by": "publisher",
      "first-page": "D480",
      "journal-title": "Nucleic Acids Res",
      "key": "441_CR20",
      "unstructured": "UniProt C. UniProt: the universal protein knowledgebase in 2021. Nucleic Acids Res. 2021;49:D480–9.",
      "volume": "49",
      "year": "2021"
    },
    {
      "DOI": "10.1093/nar/gkaa913",
      "author": "J Mistry",
      "doi-asserted-by": "publisher",
      "first-page": "D412",
      "journal-title": "Nucleic Acids Res",
      "key": "441_CR21",
      "unstructured": "Mistry J, Chuguransky S, Williams L, Qureshi M, Salazar GA, Sonnhammer ELL, Tosatto SCE, Paladin L, Raj S, Richardson LJ, et al. Pfam: the protein families database in 2021. Nucleic Acids Res. 2021;49:D412–9.",
      "volume": "49",
      "year": "2021"
    },
    {
      "DOI": "10.1093/nar/gkq603",
      "author": "K Wang",
      "doi-asserted-by": "publisher",
      "first-page": "e164",
      "journal-title": "Nucleic Acids Res",
      "key": "441_CR22",
      "unstructured": "Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38:e164.",
      "volume": "38",
      "year": "2010"
    },
    {
      "DOI": "10.1038/nprot.2015.123",
      "author": "R Vaser",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Nat Protoc",
      "key": "441_CR23",
      "unstructured": "Vaser R, Adusumalli S, Leng SN, Sikic M, Ng PC. SIFT missense predictions for genomes. Nat Protoc. 2016;11:1–9.",
      "volume": "11",
      "year": "2016"
    },
    {
      "DOI": "10.1002/0471142905.hg0720s76",
      "author": "I Adzhubei",
      "doi-asserted-by": "publisher",
      "journal-title": "Curr Protoc Hum Genet",
      "key": "441_CR24",
      "unstructured": "Adzhubei I, Jordan DM, Sunyaev SR. Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet. 2013. https://doi.org/10.1002/0471142905.hg0720s76.",
      "year": "2013"
    },
    {
      "DOI": "10.1038/ng.2892",
      "author": "M Kircher",
      "doi-asserted-by": "publisher",
      "first-page": "310",
      "journal-title": "Nat Genet",
      "key": "441_CR25",
      "unstructured": "Kircher M, Witten DM, Jain P, O’Roak BJ, Cooper GM, Shendure J. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet. 2014;46:310–5.",
      "volume": "46",
      "year": "2014"
    },
    {
      "author": "H Zou",
      "first-page": "e49",
      "journal-title": "Nucleic Acids Res",
      "key": "441_CR26",
      "unstructured": "Zou H, Pan T, Gao Y, Chen R, Li S, Guo J, Tian Z, Xu G, Xu J, Ma Y, Li Y. Pan-cancer assessment of mutational landscape in intrinsically disordered hotspots reveals potential driver genes. Nucleic Acids Res. 2022;50:e49.",
      "volume": "50",
      "year": "2022"
    },
    {
      "DOI": "10.1038/s41588-020-00774-y",
      "author": "F Cheng",
      "doi-asserted-by": "publisher",
      "first-page": "342",
      "journal-title": "Nat Genet",
      "key": "441_CR27",
      "unstructured": "Cheng F, Zhao J, Wang Y, Lu W, Liu Z, Zhou Y, Martin WR, Wang R, Huang J, Hao T, et al. Comprehensive characterization of protein-protein interactions perturbed by disease mutations. Nat Genet. 2021;53:342–53.",
      "volume": "53",
      "year": "2021"
    },
    {
      "DOI": "10.1158/2326-6066.CIR-16-0019",
      "author": "T Nathanson",
      "doi-asserted-by": "publisher",
      "first-page": "84",
      "journal-title": "Cancer Immunol Res",
      "key": "441_CR28",
      "unstructured": "Nathanson T, Ahuja A, Rubinsteyn A, Aksoy BA, Hellmann MD, Miao D, Van Allen E, Merghoub T, Wolchok JD, Snyder A, Hammerbacher J. Somatic mutations and neoepitope homology in melanomas treated with CTLA-4 blockade. Cancer Immunol Res. 2017;5:84–91.",
      "volume": "5",
      "year": "2017"
    },
    {
      "DOI": "10.1038/s41591-020-0839-y",
      "author": "DA Braun",
      "doi-asserted-by": "publisher",
      "first-page": "909",
      "journal-title": "Nat Med",
      "key": "441_CR29",
      "unstructured": "Braun DA, Hou Y, Bakouny Z, Ficial M, Sant’ Angelo M, Forman J, Ross-Macdonald P, Berger AC, Jegede OA, Elagina L, et al. Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma. Nat Med. 2020;26:909–18.",
      "volume": "26",
      "year": "2020"
    },
    {
      "DOI": "10.1186/1471-2105-14-7",
      "author": "S Hanzelmann",
      "doi-asserted-by": "publisher",
      "first-page": "7",
      "journal-title": "BMC Bioinform",
      "key": "441_CR30",
      "unstructured": "Hanzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 2013;14:7.",
      "volume": "14",
      "year": "2013"
    },
    {
      "DOI": "10.1089/omi.2011.0118",
      "author": "G Yu",
      "doi-asserted-by": "publisher",
      "first-page": "284",
      "journal-title": "OMICS",
      "key": "441_CR31",
      "unstructured": "Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16:284–7.",
      "volume": "16",
      "year": "2012"
    },
    {
      "DOI": "10.1073/pnas.0506580102",
      "author": "A Subramanian",
      "doi-asserted-by": "publisher",
      "first-page": "15545",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "441_CR32",
      "unstructured": "Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102:15545–50.",
      "volume": "102",
      "year": "2005"
    },
    {
      "DOI": "10.1016/j.cels.2015.12.004",
      "author": "A Liberzon",
      "doi-asserted-by": "publisher",
      "first-page": "417",
      "journal-title": "Cell Syst",
      "key": "441_CR33",
      "unstructured": "Liberzon A, Birger C, Thorvaldsdottir H, Ghandi M, Mesirov JP, Tamayo P. The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1:417–25.",
      "volume": "1",
      "year": "2015"
    },
    {
      "DOI": "10.1038/nmeth.3337",
      "author": "AM Newman",
      "doi-asserted-by": "publisher",
      "first-page": "453",
      "journal-title": "Nat Methods",
      "key": "441_CR34",
      "unstructured": "Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, Hoang CD, Diehn M, Alizadeh AA. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12:453–7.",
      "volume": "12",
      "year": "2015"
    },
    {
      "DOI": "10.1093/nar/gkaa407",
      "author": "T Li",
      "doi-asserted-by": "publisher",
      "first-page": "W509",
      "journal-title": "Nucleic Acids Res",
      "key": "441_CR35",
      "unstructured": "Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q, Li B, Liu XS. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48:W509–14.",
      "volume": "48",
      "year": "2020"
    },
    {
      "DOI": "10.1186/1471-2105-12-77",
      "author": "X Robin",
      "doi-asserted-by": "publisher",
      "first-page": "77",
      "journal-title": "BMC Bioinform",
      "key": "441_CR36",
      "unstructured": "Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, Muller M. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinform. 2011;12:77.",
      "volume": "12",
      "year": "2011"
    },
    {
      "DOI": "10.1073/pnas.1814684116",
      "author": "L Yu",
      "doi-asserted-by": "publisher",
      "first-page": "3636",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "441_CR37",
      "unstructured": "Yu L, Tanwar DK, Penha EDS, Wolf YI, Koonin EV, Basu MK. Grammar of protein domain architectures. Proc Natl Acad Sci USA. 2019;116:3636–45.",
      "volume": "116",
      "year": "2019"
    },
    {
      "DOI": "10.1093/nar/gkz096",
      "author": "Y Han",
      "doi-asserted-by": "publisher",
      "first-page": "e45",
      "journal-title": "Nucleic Acids Res",
      "key": "441_CR38",
      "unstructured": "Han Y, Yang J, Qian X, Cheng WC, Liu SH, Hua X, Zhou L, Yang Y, Wu Q, Liu P, Lu Y. DriverML: a machine learning algorithm for identifying driver genes in cancer sequencing studies. Nucleic Acids Res. 2019;47:e45.",
      "volume": "47",
      "year": "2019"
    },
    {
      "DOI": "10.1371/journal.pone.0196939",
      "author": "Z Wang",
      "doi-asserted-by": "publisher",
      "first-page": "e0196939",
      "journal-title": "PLoS ONE",
      "key": "441_CR39",
      "unstructured": "Wang Z, Ng KS, Chen T, Kim TB, Wang F, Shaw K, Scott KL, Meric-Bernstam F, Mills GB, Chen K. Cancer driver mutation prediction through Bayesian integration of multi-omic data. PLoS ONE. 2018;13:e0196939.",
      "volume": "13",
      "year": "2018"
    },
    {
      "DOI": "10.1186/s13059-014-0489-9",
      "author": "P Jia",
      "doi-asserted-by": "publisher",
      "first-page": "489",
      "journal-title": "Genome Biol",
      "key": "441_CR40",
      "unstructured": "Jia P, Wang Q, Chen Q, Hutchinson KE, Pao W, Zhao Z. MSEA: detection and quantification of mutation hotspots through mutation set enrichment analysis. Genome Biol. 2014;15:489.",
      "volume": "15",
      "year": "2014"
    },
    {
      "DOI": "10.1080/15548627.2019.1586251",
      "author": "KK Jena",
      "doi-asserted-by": "publisher",
      "first-page": "924",
      "journal-title": "Autophagy",
      "key": "441_CR41",
      "unstructured": "Jena KK, Mehto S, Kolapalli SP, Nath P, Sahu R, Chauhan NR, Sahoo PK, Dhar K, Das SK, Chauhan S, Chauhan S. TRIM16 governs the biogenesis and disposal of stress-induced protein aggregates to evade cytotoxicity: implication for neurodegeneration and cancer. Autophagy. 2019;15:924–6.",
      "volume": "15",
      "year": "2019"
    },
    {
      "DOI": "10.1146/annurev-virology-092917-043323",
      "author": "M van Gent",
      "doi-asserted-by": "publisher",
      "first-page": "385",
      "journal-title": "Annu Rev Virol",
      "key": "441_CR42",
      "unstructured": "van Gent M, Sparrer KMJ, Gack MU. TRIM proteins and their roles in antiviral host defenses. Annu Rev Virol. 2018;5:385–405.",
      "volume": "5",
      "year": "2018"
    },
    {
      "DOI": "10.1186/s12929-017-0374-4",
      "author": "P Czerwinska",
      "doi-asserted-by": "publisher",
      "first-page": "63",
      "journal-title": "J Biomed Sci",
      "key": "441_CR43",
      "unstructured": "Czerwinska P, Mazurek S, Wiznerowicz M. The complexity of TRIM28 contribution to cancer. J Biomed Sci. 2017;24:63.",
      "volume": "24",
      "year": "2017"
    },
    {
      "author": "CW Bacon",
      "first-page": "e1114",
      "issue": "1133–1151",
      "journal-title": "Mol Cell",
      "key": "441_CR44",
      "unstructured": "Bacon CW, Challa A, Hyder U, Shukla A, Borkar AN, Bayo J, Liu J, Wu SY, Chiang CM, Kutateladze TG, D’Orso I. KAP1 Is a chromatin reader that couples steps of RNA polymerase II transcription to sustain oncogenic programs. Mol Cell. 2020;78(1133–1151):e1114.",
      "volume": "78",
      "year": "2020"
    },
    {
      "DOI": "10.1080/15548627.2015.1034420",
      "author": "CT Pineda",
      "doi-asserted-by": "publisher",
      "first-page": "844",
      "journal-title": "Autophagy",
      "key": "441_CR45",
      "unstructured": "Pineda CT, Potts PR. Oncogenic MAGEA-TRIM28 ubiquitin ligase downregulates autophagy by ubiquitinating and degrading AMPK in cancer. Autophagy. 2015;11:844–6.",
      "volume": "11",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.cell.2015.01.034",
      "author": "CT Pineda",
      "doi-asserted-by": "publisher",
      "first-page": "715",
      "journal-title": "Cell",
      "key": "441_CR46",
      "unstructured": "Pineda CT, Ramanathan S, Fon Tacer K, Weon JL, Potts MB, Ou YH, White MA, Potts PR. Degradation of AMPK by a cancer-specific ubiquitin ligase. Cell. 2015;160:715–28.",
      "volume": "160",
      "year": "2015"
    },
    {
      "DOI": "10.2217/epi-2017-0118",
      "author": "V Modhukur",
      "doi-asserted-by": "publisher",
      "first-page": "277",
      "journal-title": "Epigenomics",
      "key": "441_CR47",
      "unstructured": "Modhukur V, Iljasenko T, Metsalu T, Lokk K, Laisk-Podar T, Vilo J. MethSurv: a web tool to perform multivariable survival analysis using DNA methylation data. Epigenomics. 2018;10:277–88.",
      "volume": "10",
      "year": "2018"
    },
    {
      "DOI": "10.3892/or.2016.4871",
      "author": "X Qiu",
      "doi-asserted-by": "publisher",
      "first-page": "811",
      "journal-title": "Oncol Rep",
      "key": "441_CR48",
      "unstructured": "Qiu X, Huang Y, Zhou Y, Zheng F. Aberrant methylation of TRIM58 in hepatocellular carcinoma and its potential clinical implication. Oncol Rep. 2016;36:811–8.",
      "volume": "36",
      "year": "2016"
    },
    {
      "DOI": "10.3389/fmolb.2021.655126",
      "author": "Y Gan",
      "doi-asserted-by": "publisher",
      "first-page": "655126",
      "journal-title": "Front Mol Biosci",
      "key": "441_CR49",
      "unstructured": "Gan Y, Cao C, Li A, Song H, Kuang G, Ma B, Zhang Q, Zhang Q. Silencing of the TRIM58 gene by aberrant promoter methylation is associated with a poor patient outcome and promotes cell proliferation and migration in clear cell renal cell carcinoma. Front Mol Biosci. 2021;8:655126.",
      "volume": "8",
      "year": "2021"
    },
    {
      "author": "M Liu",
      "first-page": "1251",
      "journal-title": "Oncol Rep",
      "key": "441_CR50",
      "unstructured": "Liu M, Zhang X, Cai J, Li Y, Luo Q, Wu H, Yang Z, Wang L, Chen D. Downregulation of TRIM58 expression is associated with a poor patient outcome and enhances colorectal cancer cell invasion. Oncol Rep. 2018;40:1251–60.",
      "volume": "40",
      "year": "2018"
    },
    {
      "DOI": "10.1126/science.1260419",
      "author": "M Uhlen",
      "doi-asserted-by": "publisher",
      "first-page": "1260419",
      "journal-title": "Science",
      "key": "441_CR51",
      "unstructured": "Uhlen M, Fagerberg L, Hallstrom BM, Lindskog C, Oksvold P, Mardinoglu A, Sivertsson A, Kampf C, Sjostedt E, Asplund A, et al. Proteomics. Tissue-based map of the human proteome. Science. 2015;347:1260419.",
      "volume": "347",
      "year": "2015"
    },
    {
      "DOI": "10.1038/nrg2918",
      "author": "AL Barabasi",
      "doi-asserted-by": "publisher",
      "first-page": "56",
      "journal-title": "Nat Rev Genet",
      "key": "441_CR52",
      "unstructured": "Barabasi AL, Gulbahce N, Loscalzo J. Network medicine: a network-based approach to human disease. Nat Rev Genet. 2011;12:56–68.",
      "volume": "12",
      "year": "2011"
    },
    {
      "DOI": "10.1038/s41580-018-0080-4",
      "author": "A Dongre",
      "doi-asserted-by": "publisher",
      "first-page": "69",
      "journal-title": "Nat Rev Mol Cell Biol",
      "key": "441_CR53",
      "unstructured": "Dongre A, Weinberg RA. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol. 2019;20:69–84.",
      "volume": "20",
      "year": "2019"
    },
    {
      "DOI": "10.1038/nrc.2016.14",
      "author": "BS Parker",
      "doi-asserted-by": "publisher",
      "first-page": "131",
      "journal-title": "Nat Rev Cancer",
      "key": "441_CR54",
      "unstructured": "Parker BS, Rautela J, Hertzog PJ. Antitumour actions of interferons: implications for cancer therapy. Nat Rev Cancer. 2016;16:131–44.",
      "volume": "16",
      "year": "2016"
    },
    {
      "DOI": "10.3390/v13020279",
      "author": "L Wang",
      "doi-asserted-by": "publisher",
      "first-page": "279",
      "journal-title": "Viruses",
      "key": "441_CR55",
      "unstructured": "Wang L, Ning S. TRIMming type I interferon-mediated innate immune response in antiviral and antitumor defense. Viruses. 2021;13:279.",
      "volume": "13",
      "year": "2021"
    },
    {
      "DOI": "10.1371/journal.pone.0004894",
      "author": "L Carthagena",
      "doi-asserted-by": "publisher",
      "first-page": "e4894",
      "journal-title": "PLoS ONE",
      "key": "441_CR56",
      "unstructured": "Carthagena L, Bergamaschi A, Luna JM, David A, Uchil PD, Margottin-Goguet F, Mothes W, Hazan U, Transy C, Pancino G, Nisole S. Human TRIM gene expression in response to interferons. PLoS ONE. 2009;4:e4894.",
      "volume": "4",
      "year": "2009"
    },
    {
      "author": "V Thorsson",
      "first-page": "e814",
      "issue": "812–830",
      "journal-title": "Immunity",
      "key": "441_CR57",
      "unstructured": "Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang TH, Porta-Pardo E, Gao GF, Plaisier CL, Eddy JA, et al. The immune landscape of cancer. Immunity. 2018;48(812–830):e814.",
      "volume": "48",
      "year": "2018"
    },
    {
      "DOI": "10.1038/s41416-021-01488-6",
      "author": "TL Rose",
      "doi-asserted-by": "publisher",
      "first-page": "1251",
      "journal-title": "Br J Cancer",
      "key": "441_CR58",
      "unstructured": "Rose TL, Weir WH, Mayhew GM, Shibata Y, Eulitt P, Uronis JM, Zhou M, Nielsen M, Smith AB, Woods M, et al. Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience. Br J Cancer. 2021;125:1251–60.",
      "volume": "125",
      "year": "2021"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-15-2738",
      "author": "EM Pinto",
      "doi-asserted-by": "publisher",
      "first-page": "6247",
      "journal-title": "Clin Cancer Res",
      "key": "441_CR59",
      "unstructured": "Pinto EM, Rodriguez-Galindo C, Choi JK, Pounds S, Liu Z, Neale G, Finkelstein D, Hicks JM, Pappo AS, Figueiredo BC, et al. Prognostic significance of major histocompatibility complex class II expression in pediatric adrenocortical tumors: a St. Jude and children’s oncology group study. Clin Cancer Res. 2016;22:6247–55.",
      "volume": "22",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.cell.2016.02.065",
      "author": "W Hugo",
      "doi-asserted-by": "publisher",
      "first-page": "35",
      "journal-title": "Cell",
      "key": "441_CR60",
      "unstructured": "Hugo W, Zaretsky JM, Sun L, Song C, Moreno BH, Hu-Lieskovan S, Berent-Maoz B, Pang J, Chmielowski B, Cherry G, et al. Genomic and transcriptomic features of response to anti-PD-1 therapy in metastatic melanoma. Cell. 2016;165:35–44.",
      "volume": "165",
      "year": "2016"
    },
    {
      "DOI": "10.1371/journal.pone.0031507",
      "author": "G Zhang",
      "doi-asserted-by": "publisher",
      "first-page": "e31507",
      "journal-title": "PLoS ONE",
      "key": "441_CR61",
      "unstructured": "Zhang G, Schetter A, He P, Funamizu N, Gaedcke J, Ghadimi BM, Ried T, Hassan R, Yfantis HG, Lee DH, et al. DPEP1 inhibits tumor cell invasiveness, enhances chemosensitivity and predicts clinical outcome in pancreatic ductal adenocarcinoma. PLoS ONE. 2012;7:e31507.",
      "volume": "7",
      "year": "2012"
    },
    {
      "DOI": "10.1155/2020/8450606",
      "author": "P Yuan",
      "doi-asserted-by": "publisher",
      "first-page": "8450606",
      "journal-title": "Biomed Res Int",
      "key": "441_CR62",
      "unstructured": "Yuan P, Zhou Y, Wang R, Chen S, Wang Q, Xu Z, Liu Y, Yang H. TRIM58 interacts with pyruvate kinase M2 to inhibit tumorigenicity in human osteosarcoma cells. Biomed Res Int. 2020;2020:8450606.",
      "volume": "2020",
      "year": "2020"
    },
    {
      "DOI": "10.3389/fonc.2021.695740",
      "author": "R Li",
      "doi-asserted-by": "publisher",
      "first-page": "695740",
      "journal-title": "Front Oncol",
      "key": "441_CR63",
      "unstructured": "Li R, Zhu L, Peng Y, Zhang X, Dai C, Liu D. TRIM50 suppresses pancreatic cancer progression and reverses the epithelial-mesenchymal transition via facilitating the ubiquitous degradation of snail1. Front Oncol. 2021;11:695740.",
      "volume": "11",
      "year": "2021"
    },
    {
      "DOI": "10.2147/OTT.S289922",
      "author": "Q Lan",
      "doi-asserted-by": "publisher",
      "first-page": "1429",
      "journal-title": "Onco Targets Ther",
      "key": "441_CR64",
      "unstructured": "Lan Q, Tan X, He P, Li W, Tian S, Dong W. TRIM11 promotes proliferation, migration, invasion and EMT of gastric cancer by activating beta-catenin signaling. Onco Targets Ther. 2021;14:1429–40.",
      "volume": "14",
      "year": "2021"
    },
    {
      "DOI": "10.1016/j.ejphar.2020.173090",
      "author": "C Yunna",
      "doi-asserted-by": "publisher",
      "first-page": "173090",
      "journal-title": "Eur J Pharmacol",
      "key": "441_CR65",
      "unstructured": "Yunna C, Mengru H, Lei W, Weidong C. Macrophage M1/M2 polarization. Eur J Pharmacol. 2020;877:173090.",
      "volume": "877",
      "year": "2020"
    },
    {
      "author": "YJ Li",
      "first-page": "2365",
      "journal-title": "Exp Ther Med",
      "key": "441_CR66",
      "unstructured": "Li YJ, Zhang GP, Zhao F, Li RQ, Liu SJ, Zhao ZR, Wang X. Target therapy of TRIM-14 inhibits osteosarcoma aggressiveness through the nuclear factor-kappaB signaling pathway. Exp Ther Med. 2018;15:2365–73.",
      "volume": "15",
      "year": "2018"
    }
  ],
  "reference-count": 66,
  "references-count": 66,
  "resource": {
    "primary": {
      "URL": "https://humgenomics.biomedcentral.com/articles/10.1186/s40246-022-00441-9"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genomics"
  ],
  "source": "Crossref",
  "title": [
    "Pan-cancer illumination of TRIM gene family reveals immunology regulation and potential therapeutic implications"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "16"
}